Drospirenone and VTE

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Risk of venous thromboembolism with drospirenone-containing oral contraceptives.

PURPOSE The risk of venous thromboembolism (VTE) with drospirenone-containing oral contraceptives (OCs) is reviewed. SUMMARY Increasing attention and media have raised awareness and concern about whether drospirenone-containing OCs increase the risk of VTE. Two studies found that when compared with nonuse of OCs, use of drospirenone-containing OCs was associated with a fourfold to over sixfol...

متن کامل

Venous Thromboembolism (vte)

Epidemiology (CDC, Beckman, Am J Prev Med, 2010) ●Includes deep venous thrombosis (DVT) and pulmonary embolism (PE) and affects more than 300,000 to 600,000 patients annually with 60,000-100,000 deaths (some estimates as high as 300,000); AHRQ estimates 2 million affected per year and 200,000 deaths; 50% develop during admission or within 30 days after hospitalization ●PE remains most common pr...

متن کامل

Review: Flight times >8 hours and presence of risk factors for VTE increases travel related VTE.

M e t h o d s Data sources: MEDLINE (1966 to December 2005), Cochrane Central Register of Controlled Trials, Database of Abstracts of Reviews of Effects, and bibliographies of relevant studies. Study selection and assessment: Case–control or cohort studies and randomized controlled trials (RCTs) that evaluated any form of travel as a risk factor for VTE or preventive measures for travel-related...

متن کامل

Drospirenone: an antihypertensive in waiting.

Drospirenone (DRSP) is a compound with mingled identities having been viewed as a diuretic,1 a progestational agent,2 and/or an antimineralocorticoid agent with an ability to reduce blood pressure (BP).3– 6 The multiple personalities of this compound can be seen by examining the position adopted by the United States AntiDoping Agency on its use as a diuretic in athletes. Until January 2005, ath...

متن کامل

Antithrombotic Therapy for VTE Disease

2.1. In patients with acute DVT of the leg treated with vitamin K antagonist (VKA) therapy, we Background: This article addresses the treatment of VTE disease. Methods: We generated strong (Grade 1) and weak (Grade 2) recommendations based on highquality (Grade A), moderate-quality (Grade B), and low-quality (Grade C) evidence. Results: For acute DVT or pulmonary embolism (PE), we recommend ini...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Family Planning and Reproductive Health Care

سال: 2010

ISSN: 1471-1893

DOI: 10.1783/147118910790291127